Screener
Apogee Therapeutics, Inc. APGE Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development (1) | $60,819 | $46,387 |
| General and administrative | 21,953 | 16,709 |
| Total operating expenses | 82,772 | 63,096 |
| Loss from operations | (82,772) | (63,096) |
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s other operating expenses?
- Apogee Therapeutics, Inc. (APGE) reported other operating expenses of $82.77M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Apogee Therapeutics, Inc.'s other operating expenses increased by 31.2% year-over-year, from $63.1M to $82.77M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s other operating expenses?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s other operating expenses has grown at a 75.2% compound annual growth rate (CAGR), from $93M to $285.6M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Apogee Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude